Search Results 181-190 of 15165 for IUD

  1. A Study to Evaluate a Wearable Biosensor and Mobile Platform in Endometriosis Patients - Mayo Clinic

    ... IUDs MORE THAN 12 WEEKS prior to the study participation, AND stable use of the medication is expected during the study period 6. Patient has a moderate to ...

  2. HPV infection - Doctors and departments - Mayo Clinic

    ... Intrauterine ...device method, Female hormone replacement therapy, Loop electrosurgical excision procedure, Cervical biopsy, Vulvar biopsy, Vaginal biopsy ...

  3. A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery - Mayo Clinic

    of contraception or placement of an intrauterine device (IUD) or intrauterine system (IUS), or other forms of hormonal contraception that have comparable

  4. Efficacy of Nerve Blocks for Episodic Migraine - Mayo Clinic

    - Intrauterine device (IUD); - Total hysterectomy or tubal ligation; - Abstinence (no sex). - Allergy or documented contraindication to amide anesthetics ...

  5. A Patient Access Program of Olaratumab for the Continued Treatment of Soft Tissue Sarcoma - Mayo Clinic

    ... (IUDs), sexual abstinence, or a vasectomized partner. Exclusion Criteria: Breastfeeding (patients who discontinue breastfeeding would be considered eligible) ...

  6. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

    Intrauterine device (IUD);; Intrauterine hormone-releasing system (IUS);; To have a vasectomized sexual partner(s) (the vasectomized partner[s] has received ...

  7. Importance of pre-pregnancy care for women with diabetes: A case from the endocrine teaching clinics

    At six months, the patient's HbA1c had improved to 6.2% and her intrauterine device was removed. Three months later the woman became pregnant. She was ...

  8. A Study to Evaluate the Efficacy and Safety of Colchicine on Coronavirus SARS-CoV2 Positive Adults - Mayo Clinic

    ... intrauterine device (IUD)) throughout the study and for 30 days after study completion; Patient must be able and willing to comply with the requirements of ...

  9. A Study of the Long-Term Safety, Tolerability, and Effectiveness of Tesevatinib for Patients Completing 24 Months of Treatment for Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Participation eligibility · IUD plus one barrier method · Stable doses of hormonal contraception for at least 3 months (eg, oral, injectable, implant, transdermal) ...

  10. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) - Mayo Clinic

    ... intrauterine device (IUD), or male partner with a vasectomy. A double-barrier method such as condoms, diaphragms or cervical caps with spermicidal foam ...